The 5th Next Generation Gene Therapy Vectors Summit Recent announcements from major pharmaceutical companies scaling back their AAV gene therapy pipelines have raised concerns across the field. However, this is not the end. It is an opportunity to reset, refocus, and rise to the challenge. While issues such as liver toxicity, pre-existing antibodies, and high manufacturing costs remain significant, so […]

As demand for radiopharmaceuticals rises, the industry is focused on strengthening isotope supply, improving patient access, and accelerating therapeutic development. Join us at the 4th Targeted Radiopharmaceuticals Summit US in San Diego this July for the premier platform dedicated to radiopharmaceutical therapeutics and theranostics, featuring: 50+ Expert Speakers from leading biotech, pharma, and research institutions, including Ratio […]

The Operationalize: Expanded Access Programs Summit West is coming to San Francisco! (July 29-31). Following the successful Boston and London meetings, the Operationalize Expanded Access Programs Summit West is uniting stakeholders executing Early Access, Expanded Access and Post-Trial Access Programs to share expertise in successfully bridging the gap between innovative clinical research and patients in need. This Summit is […]

The landscape of Fc-mediated therapies is undergoing a radical transformation, driven by precise Fc-receptor targeting and antibody domain modification to unlock new levels of efficacy and safety for unprecedented therapeutic potential in oncology and autoimmune disease treatment. The 5th Fc-Mediated Function Summit is the essential destination for experts driving innovation in Fc-receptor targeting and antibody […]

Join us this August in Boston, MA for the 9th LEAP HR: Life Sciences East. Connect with 200+ leadership professionals in biopharma dedicated to attracting, retaining and developing critical talent to deliver their organizations mission. Engage with HR leaders who are also navigating a period of uncertainty amongst: regulation changes, financial uncertainties, supply chain disruptions, […]

As dual-payload and novel MoA payload ADCs continue to reshape the therapeutic landscape, the 3rd ADC Linker & Conjugation Summit returns as the definitive forum for ADC chemists and bioconjugation specialists aiming to overcome persistent challenges in hydrophobicity, aggregation, and linker stability. This three-day technical deep dive is your chance to: Discover next-generation conjugation strategies and site-specific […]

This August, the 9th IPF Summit returns as the industry’s must attend summit, providing an essential platform for the entire community to gather and dissect the latest breakthroughs and setbacks, to shape the future of pulmonary fibrosis drug development. Be one of the first to view the agenda here: https://ter.li/moky9n A Snapshot of What Awaits […]

In a year where neurology has overtaken cancer as the number one indication prioritized by oligonucleotide drug developers, now is the time to stay at forefront of ASO and siRNA innovation. Returning to Boston, this August, the 5th Oligonucleotides for CNS Summit unites 100+ biopharma leaders across RNA biology, oligonucleotide chemistry, DMPK, pharmacology, and platform […]